TY - JOUR
T1 - Comparison of postoperative morbidity between simultaneous bilateral and staged bilateral total knee arthroplasties
T2 - Serological perspective and clinical consequences
AU - Niki, Yasuo
AU - Katsuyama, Eri
AU - Takeda, Yuki
AU - Enomoto, Hiroyuki
AU - Toyama, Yoshiaki
AU - Suda, Yasunori
PY - 2014/3
Y1 - 2014/3
N2 - The present study compared simultaneous and two-staged (stages 1 and 2 with 8-month interval on average) bilateral TKAs in terms of postoperative serological status and clinical consequences. The decrease in hemoglobin over 2. weeks postoperatively was similar between groups. C-reactive protein levels and creatine phosphokinase index peaking on day 2 were significantly higher in the simultaneous group than in either staged group (P< 0.05). Incidence of DVT on day 7 tended to be higher in the simultaneous group, but the difference was not significant. Considering the approximately 8-month interval and 2-month earlier functional recovery with stage 2 TKAs, 6. months were saved with the simultaneous bilateral TKA group. Collectively, simultaneous bilateral TKA is likely to offer a safe and effective procedure in appropriate clinical settings involving anti-bleeding and anti-venous thromboembolism prophylaxis.
AB - The present study compared simultaneous and two-staged (stages 1 and 2 with 8-month interval on average) bilateral TKAs in terms of postoperative serological status and clinical consequences. The decrease in hemoglobin over 2. weeks postoperatively was similar between groups. C-reactive protein levels and creatine phosphokinase index peaking on day 2 were significantly higher in the simultaneous group than in either staged group (P< 0.05). Incidence of DVT on day 7 tended to be higher in the simultaneous group, but the difference was not significant. Considering the approximately 8-month interval and 2-month earlier functional recovery with stage 2 TKAs, 6. months were saved with the simultaneous bilateral TKA group. Collectively, simultaneous bilateral TKA is likely to offer a safe and effective procedure in appropriate clinical settings involving anti-bleeding and anti-venous thromboembolism prophylaxis.
UR - http://www.scopus.com/inward/record.url?scp=84893865036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84893865036&partnerID=8YFLogxK
U2 - 10.1016/j.arth.2013.07.019
DO - 10.1016/j.arth.2013.07.019
M3 - Article
C2 - 23988436
AN - SCOPUS:84893865036
SN - 0883-5403
VL - 29
SP - 504
EP - 509
JO - Journal of Arthroplasty
JF - Journal of Arthroplasty
IS - 3
ER -